ArticleSisli Etfal Hastanesi tip bulteni2026
Interscalene Block versus Posterior Suprascapular Block for Postoperative Analgesia on Arthroscopic Shoulder Surgery: Randomized, Controlled, Prospective Study.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analgesic Efficacy and Motor-Sparing Properties of Superior Trunk Block versus Interscalene Brachial Plexus Block with Liposomal Bupivacaine for Shoulder Arthroscopy: A Randomized Controlled Trial.Drug design, development and therapy · 2026Trial
- Comment on Ozler et al.: "Interscalene Block Versus Posterior Suprascapular Block for Postoperative Analgesia in Arthroscopic Shoulder Surgery".Sisli Etfal Hastanesi tip bulteni · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to compare the effects of interscalene block and posterior suprascapular nerve block on postoperative analgesia in the first 24 hours after unilateral arthroscopic shoulder surgery. Methods: Ninety-eight adult patients aged between 18 and 65 years, with ASA (American Society of Anesthesiologists) physical status I-II, undergoing elective arthroscopic shoulder surgery were included in this prospective, randomized controlled study. All patients were randomized into two groups: the interscalene block group (Group ISB, n=48) and the suprascapular block group (Group SSB, n=50). Both groups received 10 mL of 0.5% bupivacaine. The duration of analgesia, total opioid consumption, complications, and Visual Analog Scale (VAS) scores were recorded at postoperative 0, 1, 4, 6, 12, and 24 hours. Results: Statistical data were analyzed in 87 patients after 7 patients from Group SSNB and 4 patients from Group ISB were excluded from the study. There was no significant difference between the two groups in analgesia duration, total opioid consumption, and patient satisfaction. While VAS values at 0 hours (p<0.01), 1 hour (p<0.05), 4 hours (p<0.01), and 6 hours (p<0.01) were lower in Group ISB, the VAS value at the 12th hour was similar between Group SSB and Group ISB (p>0.05). However, the VAS value at the 24th hour was lower in Group SSB (p<0.01). The complication rate was higher in Group ISB (p<0.01). Conclusion: It was concluded that ultrasound-guided posterior SSB for postoperative pain after arthroscopic shoulder surgery is not equivalent to ISB, especially in the early postoperative period, but it is an effective alternative technique with fewer side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.